Two Seas Capital LP

Holdings History for Adaptimmune Therapeutics PLC - Ordinary Shares, par value GBP 0.001 per share (ADAP)

Symbol: ADAP on Nasdaq
Investment type: Equity - Shares of Stock
Class: Ordinary Shares, par value GBP 0.001 per share
Latest Disclosed Ownership: 89M shares
Security Ownership: 5.8%

Shares, Excluding Options vs Price

Value, Excluding Options

Two Seas Capital LP ownership in Adaptimmune Therapeutics PLC Ordinary Shares, par value GBP 0.001 per share (ADAP)

2025-02-14 - Two Seas Capital LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 89M shares of Adaptimmune Therapeutics PLC Ordinary Shares, par value GBP 0.001 per share (ADAP). This represents 5.8% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Two Seas Capital LP	5.8%		$52.5M	89M			$0.59	13G	12/31/2024	14 Feb 2025 09:31:31

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024		0.94%	+0.94%	$7.99M	14.8M	+14,835,146	NEW	$0.54	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.